✦ LIBER ✦

Consensus protocol for the use of recombinant activated factor VII [eptacog alfa (activated); NovoSeven®] in elective orthopaedic surgery in haemophilic patients with inhibitors

✍ Scribed by P. L. F. GIANGRANDE; J. T. WILDE; B. MADAN; C. A. LUDLAM; E. G. D. TUDDENHAM; N. J. GODDARD; G. DOLAN; J. INGERSLEV

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Recombinant activated factor VII for hae

✍ A. OBERGFELL; M.-K. AUVINEN; P. MATHEW 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 83 KB

Recombinant factor VIIa analog (vatrepta

✍ ERICH V. DE PAULA; KAAN KAVAKLI; JOHNNY MAHLANGU; YASMIN AYOB; STEVEN R. LENTZ; 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 231 KB

Cost effectiveness of recombinant activa

✍ S. Morris; S. Ridley; V. Munro; M. C. Christensen; the NovoSeven® Trauma Study G 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 527 KB

Use of recombinant activated factor VII

✍ B. Gail Macik; John Hohneker; H. R. Roberts; Anne M. Griffin 📂 Article 📅 1989 🏛 John Wiley and Sons 🌐 English ⚖ 254 KB 👁 2 views

Single-dose (270 μg kg−1) recombinant ac

✍ B. PAN-PETESCH; P. LAGUNA; A. MITAL; J. STANLEY; M. F. TORCHET; S. Z. SALEK; P. 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 60 KB